EUVIMEDEUVIMED entdecken
Netzwerk-Metaanalyse

Antibiotic Prophylaxis for Spontaneous Bacterial Peritonitis in Cirrhosis: A Network Meta-analysis of Randomized Trials

Moon Haeng Hur, Sang Gyune Kim, Yaeji Lim, Juseong Park, Suhyeok Ham, Han Ah Lee, Miyoung Choi

Clinical and Molecular Hepatology · 17.11.2026

DOI: 10.3350/cmh.2026.0798 ↗

Kurz gefasst

Netzwerk-Metaanalyse in der Zeitschrift Clinical and Molecular Hepatology, online erschienen am 17.11.2026. Verfasst von Moon Haeng Hur und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: The relative efficacy of antibiotic prophylaxis for spontaneous bacterial peritonitis (SBP) remains uncertain. We performed a network meta-analysis of randomized controlled trials (RCTs) of prophylactic antibiotic regimens.

Methods

We searched PubMed, Embase, Cochrane Library, and Web of Science for RCTs of antibiotic prophylaxis in cirrhosis. Primary outcomes were SBP incidence and all-cause mortality.

Results

Twenty-eight RCTs were included. For all-cause mortality, the network was coherent, and rifaximin (risk ratio [RR], 0.50; 95% confidence interval [CI], 0.33-0.76), trimethoprim-sulfamethoxazole (RR, 0.48; 95% CI, 0.25-0.90), norfloxacin plus rifaximin (RR, 0.38; 95% CI, 0.17-0.86), and norfloxacin (RR, 0.69; 95% CI, 0.52-0.91) were associated with lower mortality. For SBP incidence, node-splitting revealed significant incoherence for rifaximin (P=0.015): direct evidence from five double-blind placebo-controlled trials (RR, 0.58; 95% CI, 0.27-1.25) diverged from indirect evidence via open-label head-to-head trials (RR, 0.15; 95% CI, 0.07-0.33). In primary prophylaxis, rifaximin (RR, 0.41; 95% CI, 0.22-0.76), norfloxacin (RR, 0.41; 95% CI, 0.22-0.78), and norfloxacin plus rifaximin (RR, 0.28; 95% CI, 0.10-0.75) reduced SBP incidence. In secondary prophylaxis, rifaximin showed the largest reduction in recurrence (RR, 0.08; 95% CI, 0.02-0.29), anchored on one placebo-controlled trial. The preventive effect attenuated with calendar year for SBP (ratio of risk ratios, 1.038 per year; 95% CI, 1.008-1.068; P=0.012) but not for mortality.

Conclusions

Antibiotic prophylaxis is associated with lower all-cause mortality in cirrhosis with ascites, with rifaximin showing the most consistent survival benefit. However, its SBP estimate was not reproduced in blinded placebo-controlled trials, and the preventive effect against SBP attenuated over time.

Schlagwörter

Stichwörter der Autor:innen

Antibiotic prophylaxisLiver cirrhosisNetwork meta-analysisRifaximinSpontaneous bacterial peritonitis

Autor:innen und Institutionen

  • Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.
  • Department of Applied Statistics, Chung-Ang University, Seoul, Korea.
  • Department of Statistics and Data Science, Chung-Ang University, Seoul, Korea.
  • Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea. amelia86@naver.com.
  • Division of Healthcare Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Korea. mychoi@neca.re.kr.

Zitieren

APA

Hur, M. H., Kim, S. G., Lim, Y., Park, J., Ham, S., Lee, H. A., & Choi, M. (2026). Antibiotic Prophylaxis for Spontaneous Bacterial Peritonitis in Cirrhosis: A Network Meta-analysis of Randomized Trials. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.0798

Vancouver

Hur MH, Kim SG, Lim Y, Park J, Ham S, Lee HA, et al. Antibiotic Prophylaxis for Spontaneous Bacterial Peritonitis in Cirrhosis: A Network Meta-analysis of Randomized Trials. Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2026.0798

BibTeX
@article{Hur2026,
  author = {Hur, Moon Haeng and Kim, Sang Gyune and Lim, Yaeji and Park, Juseong and Ham, Suhyeok and Lee, Han Ah and Choi, Miyoung},
  title = {Antibiotic Prophylaxis for Spontaneous Bacterial Peritonitis in Cirrhosis: A Network Meta-analysis of Randomized Trials},
  journal = {Clinical and Molecular Hepatology},
  year = {2026},
  doi = {10.3350/cmh.2026.0798}
}
Kostenlos starten →